Clinical Trial Site

Moscow

0 studies enrolling now · 4 studies all time

What they study most

Atypical Hemolytic Uremic Syndrome (aHUS), Hemophilia A, Hemophilia B, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B — Completed
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed
• A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria — Completed
• A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients — Completed